biomarker

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

biomarker
Oct 3, 2024, 00:05 | Insight
Tamoor Sial: Diving into the world of biotech content
Tamoor Sial, Business Development Manager at Inovi, shared on LinkedIn: “Diving into the world of…
Sep 6, 2024, 17:13 | Insight
Ashley Easter reflecting on his journey at AstraZeneca
Ashley Easter shared a post on LinkedIn: “Seven years ago, I had the opportunity to…
Aug 26, 2024, 20:57 | Blog
Register for SITC Winter School 2025 - Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer shared a post on X: “Register for Society for Immunotherapy…
Aug 10, 2024, 17:53 | Insight
Stephen Liu: Biomarker results and the timing for lung cancer treatment
Stephen Liu shared on X: "It's critical to wait for biomarker results before starting treatment for…
Jul 28, 2024, 13:53 | Blog
Thomas Fuchs: Virchow Foundation Model capable of characterizing the morphology of cancer at unprecedented acuity
Thomas Fuchs,  Department Chair of Artificial Intelligence and Human Health in Icahn School of Medicine…
Jul 15, 2024, 21:23 | Insight
Adar Yaacov: Our manuscript on MESiCA is out in Cell Reports Medicine
Adar Yaacov, Senior Bioinformatics Data Scientist at Protica Bio, shared a post on X about…
Jun 12, 2024, 02:24 | Blog
Abstract submissions for ProCan Conference are open!
ProCan Conference, ‘Advancing Multi-Omics into the Clinic’ is taking place in Sydney, Australia on November…
Jun 9, 2024, 02:45 | Insight
Brian Rini: KIM-1 is a novel prognostic and predictive biomarker in RCC
Toni Choueiri shared a post by Brian Rini, Chief of Clinical Trials at Vanderbilt University, on X/Twitter:…
Apr 17, 2024, 19:06 | Drugs
New research from Dr. Jung-Min Lee has identified a potential drug to treat ovarian cancers - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "Milestones Monday: Ovarian cancer is the most lethal…
Dec 8, 2023, 17:40 | Insight
Ibrahim Halil Sahin: A common question I received after my tweet on the PEGASUS trial...
Ibrahim Halil Sahin, GI Medical Oncologist at UPMC, shared on X/Twitter: "A common question I…
Aug 19, 2023, 19:19 | Opinion
Armen Asatryan: "Accelerated Approval". This is, in my experience, probably one of the biggest misnomers in the United States pharma regulatory world.
Quoting  Armen Asatryan, Founder & CEO, iClinDev Consulting on LinkedIn: " 'Accelerated Approval'. This is,…
Aug 13, 2023, 08:56 | Insight
Stephen V Liu: More data showing the importance of *waiting* for NGS results before starting non–small-cell lung cancer therapy whenever possible!
As per Stephen V. Liu, the Director of Thoracic Oncology and Head of Developmental Therapeutics at…
Aug 8, 2023, 19:05 | Societies
Over 500 attendees for 2023 American Society of Clinical Oncology (ASCO) Best of ASCO meeting in Seattle - Ishwaria Subbiah
⏱️ July reflections — Over 500 attendees for the 2023 American Society of Clinical Oncology…
Jul 22, 2023, 18:35 | Stories
What from ASCO Annual Mtg ASCO23 should I know when I start my clinic on Monday? - Ishwaria Subbiah
A final tweak of the slides en route to Seattle for the 2023 Best of…
Jul 18, 2023, 19:54 | Stories
Time to do NGS on all cancers, and study every cancer molecularly/genetically - Sucharu Prakash
It is time! Time to do NGS on all cancers, and study every cancer molecularly/genetically.…
Jul 17, 2023, 07:12 | Blog
KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10
Jul 14, 2023, 19:45 | Stories
A magic mirror for CAR-T cells - Wolfgang Wagner
A magic mirror for CAR-T cells! It is great please to share this work on…
All: 17 Posts: 1 - 100
Special Coverage